News

Shimadzu 8th Global Pharma Summit 2021 16.11.2021

Shimadzu 8th Global Pharma Summit 2021

Shimadzu 8th Global Pharma Summit delves into Digital Transformation (DX) solutions that allow you to capitalize on the benefits of Pharma 4.0. Come and learn about Drug Discovery, Machine [...]

Meet us at the virtual MSACL 2021 EU! 31.08.2021

Meet us at the virtual MSACL 2021 EU!

Alsachim and Shimadzu Europe participate in MSACL 2021, the European event for mass spectrometry and advances in the clinical laboratory. This year, the congress has shifted to Virtual-Only and [...]

Antiepileptic standards: discover the selection for your LC-MS/MS analyses 08.02.2021

Antiepileptic standards: discover the selection for your LC-MS/MS analyses

Alsachim has synthesized a full list of Antiepileptic standards, one of the most commonly studied molecules for their mechanism of action and therapeutic use.  It is estimated that more than 50 [...]

Customer voice: DOSINACO reagent kit 08.02.2021

Customer voice: DOSINACO reagent kit

Towards simplification of therapeutic drug monitoring with DOSINACO kit for anticoagulants. Precision medicine improves safety and efficacy of therapies We chose DOSINACO [...]

Products Catalog: Tyrosine Kinase Inhibitors 09.12.2020

Products Catalog: Tyrosine Kinase Inhibitors

Alsachim has synthesized a full set of labeled and unlabeled Tyrosine Kinase Inhibitors standards. During the last decades, targeted therapy has been introduced as an alternative treatment in [...]

Analysis of Favipiravir in human plasma 06.11.2020

Analysis of Favipiravir in human plasma

Discover 2 new methods for the analysis of the antiviral Favipiravir in human plasma. An analytical method developed by Shimadzu's teams by LC-MS/MS (LCMS-8060) and using the stable isotope [...]